Donor-specific mononuclear cell transfusion and methotrexate as pretransplant treatment in dogs given DLA-identical marrow grafts after nonmyeloablative conditioning.
Jochum
Christoph
C
Beste
Mechthild
M
Zellmer
Eustacia
E
Graves
Scott S
SS
Storb
Rainer
R
Storb
Rainer
R
D000818:Animals; D016026:Bone Marrow Transplantation; D004285:Dogs; D004307:Dose-Response Relationship, Radiation; D006085:Graft Survival / Q000528:radiation effects*; D006086:Graft vs Host Disease / Q000517:prevention & control; D015395:Histocompatibility Antigens Class I; D017708:Leukocyte Transfusion; D013997:Time Factors; D019172:Transplantation Conditioning / Q000379:methods; D014916:Whole-Body Irradiation / Q000379:methods
D015395:Histocompatibility Antigens Class I